Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer

BackgroundThe current tumor-node-metastasis (TNM) staging system is insufficient for predicting the efficacy of chemotherapy in patients with gastric cancer (GC). This study aimed to analyze the association between the focal adhesion pathway and therapeutic efficacy of chemotherapy in patients with...

Full description

Bibliographic Details
Main Authors: Xiaohuan Tang, Xiaolong Wu, Ting Guo, Fangzhou Jia, Ying Hu, Xiaofang Xing, Xiangyu Gao, Ziyu Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.808817/full
_version_ 1818476078680768512
author Xiaohuan Tang
Xiaolong Wu
Ting Guo
Fangzhou Jia
Ying Hu
Xiaofang Xing
Xiangyu Gao
Ziyu Li
author_facet Xiaohuan Tang
Xiaolong Wu
Ting Guo
Fangzhou Jia
Ying Hu
Xiaofang Xing
Xiangyu Gao
Ziyu Li
author_sort Xiaohuan Tang
collection DOAJ
description BackgroundThe current tumor-node-metastasis (TNM) staging system is insufficient for predicting the efficacy of chemotherapy in patients with gastric cancer (GC). This study aimed to analyze the association between the focal adhesion pathway and therapeutic efficacy of chemotherapy in patients with GC.MethodsRNA sequencing was performed on 33 clinical samples from patients who responded or did not respond to treatment prior to neoadjuvant chemotherapy. The validation sets containing 696 GC patients with RNA data from three cohorts (PKUCH, TCGA, and GSE14210) were analyzed. A series of machine learning and bioinformatics approaches was combined to build a focal adhesion-related signature model to predict the treatment efficacy and prognosis of patients with GC.ResultsAmong the various signaling pathways associated with cancer, focal adhesion was identified as a risk factor related to the treatment efficacy of chemotherapy and prognosis in patients with GC. The focal adhesion-related gene model (FAscore) discriminated patients with a high FAscore who are insensitive to neoadjuvant chemotherapy in our training cohort, and the predicted value was further verified in the GSE14210 cohort. Survival analysis also demonstrated that patients with high FAscores had a relatively shorter survival compared to those with low FAscores. In addition, we found that the levels of tumor mutation burden (TMB) and microsatellite instability (MSI) increased with an increase in FAscore, and the tumor microenvironment (TME) also shifted to a pro-tumor immune microenvironment.ConclusionThe FAscore model can be used to predict the treatment efficacy of chemotherapy and select appropriate treatment strategies for patients with GC.
first_indexed 2024-12-10T09:20:55Z
format Article
id doaj.art-185eb0d7fa4c447981e809d27c47b521
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-10T09:20:55Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-185eb0d7fa4c447981e809d27c47b5212022-12-22T01:54:42ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-05-011210.3389/fonc.2022.808817808817Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric CancerXiaohuan Tang0Xiaolong Wu1Ting Guo2Fangzhou Jia3Ying Hu4Xiaofang Xing5Xiangyu Gao6Ziyu Li7Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, ChinaBiological Sample Bank, Peking University Cancer Hospital & Institute, Beijing, ChinaBiological Sample Bank, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, ChinaBackgroundThe current tumor-node-metastasis (TNM) staging system is insufficient for predicting the efficacy of chemotherapy in patients with gastric cancer (GC). This study aimed to analyze the association between the focal adhesion pathway and therapeutic efficacy of chemotherapy in patients with GC.MethodsRNA sequencing was performed on 33 clinical samples from patients who responded or did not respond to treatment prior to neoadjuvant chemotherapy. The validation sets containing 696 GC patients with RNA data from three cohorts (PKUCH, TCGA, and GSE14210) were analyzed. A series of machine learning and bioinformatics approaches was combined to build a focal adhesion-related signature model to predict the treatment efficacy and prognosis of patients with GC.ResultsAmong the various signaling pathways associated with cancer, focal adhesion was identified as a risk factor related to the treatment efficacy of chemotherapy and prognosis in patients with GC. The focal adhesion-related gene model (FAscore) discriminated patients with a high FAscore who are insensitive to neoadjuvant chemotherapy in our training cohort, and the predicted value was further verified in the GSE14210 cohort. Survival analysis also demonstrated that patients with high FAscores had a relatively shorter survival compared to those with low FAscores. In addition, we found that the levels of tumor mutation burden (TMB) and microsatellite instability (MSI) increased with an increase in FAscore, and the tumor microenvironment (TME) also shifted to a pro-tumor immune microenvironment.ConclusionThe FAscore model can be used to predict the treatment efficacy of chemotherapy and select appropriate treatment strategies for patients with GC.https://www.frontiersin.org/articles/10.3389/fonc.2022.808817/fullgastric cancerfocal adhesiontreatment efficacyprognosistumor microenvironment
spellingShingle Xiaohuan Tang
Xiaolong Wu
Ting Guo
Fangzhou Jia
Ying Hu
Xiaofang Xing
Xiangyu Gao
Ziyu Li
Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer
Frontiers in Oncology
gastric cancer
focal adhesion
treatment efficacy
prognosis
tumor microenvironment
title Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer
title_full Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer
title_fullStr Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer
title_full_unstemmed Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer
title_short Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer
title_sort focal adhesion related signatures predict the treatment efficacy of chemotherapy and prognosis in patients with gastric cancer
topic gastric cancer
focal adhesion
treatment efficacy
prognosis
tumor microenvironment
url https://www.frontiersin.org/articles/10.3389/fonc.2022.808817/full
work_keys_str_mv AT xiaohuantang focaladhesionrelatedsignaturespredictthetreatmentefficacyofchemotherapyandprognosisinpatientswithgastriccancer
AT xiaolongwu focaladhesionrelatedsignaturespredictthetreatmentefficacyofchemotherapyandprognosisinpatientswithgastriccancer
AT tingguo focaladhesionrelatedsignaturespredictthetreatmentefficacyofchemotherapyandprognosisinpatientswithgastriccancer
AT fangzhoujia focaladhesionrelatedsignaturespredictthetreatmentefficacyofchemotherapyandprognosisinpatientswithgastriccancer
AT yinghu focaladhesionrelatedsignaturespredictthetreatmentefficacyofchemotherapyandprognosisinpatientswithgastriccancer
AT xiaofangxing focaladhesionrelatedsignaturespredictthetreatmentefficacyofchemotherapyandprognosisinpatientswithgastriccancer
AT xiangyugao focaladhesionrelatedsignaturespredictthetreatmentefficacyofchemotherapyandprognosisinpatientswithgastriccancer
AT ziyuli focaladhesionrelatedsignaturespredictthetreatmentefficacyofchemotherapyandprognosisinpatientswithgastriccancer